[Chemotherapy of solid tumors: pharmacologic activity or effectiveness?].
Longo
F
F
Mansueto
G
G
D000260:Adenoviruses, Human; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003587:Cytomegalovirus; D000077143:Docetaxel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology; D043823:Taxoids; D059004:Topoisomerase I Inhibitors; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D011838:Radiation-Sensitizing Agents; D043823:Taxoids; D059004:Topoisomerase I Inhibitors; D016159:Tumor Suppressor Protein p53; D000077143:Docetaxel; D000077146:Irinotecan; D017239:Paclitaxel; D002166:Camptothecin